The first is the idea of pre-exposure prophylaxis in other words, giving ARVs to uninfected people to clobber any new infection before it can get going.
In another trial called PrEP -- pre-exposure prophylaxis -- the CDC is also studying whether antiretroviral pills are safe and effective in preventing HIV infection.